Insight Molecular Diagnostics
Price & Volume
Stats
See moreOpen | $4.40 |
Previous Close | $4.30 |
Day Range | $4.31-$4.45 |
52W Range | $2.33-$8.51 |
Market Cap | $143.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $1.6M |
Revenue Growth (YoY) | -53.9% |
Gross Profit (12 Mos) | $814,000 |
Diluted EPS | -$1.55 |
News
See moreYahoo Finance • 2 months ago
Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
Yahoo Finance • 3 months ago
Insight Molecular Diagnostics expects about $0.25M Q2 2026 revenue while projecting second-quarter cash burn above $9M
Yahoo Finance • 5 months ago
Insight Molecular Diagnostics outlines $2B annual market opportunity and signals rapid commercialization push for GraftAssureDx
Yahoo Finance • 10 months ago
iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch
About
CEO | Mr. Joshua Riggs |
Address | 2 International Plaza Dr., Nashville, TN, United States, 37217 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 55 |